Overview
A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2009-03-01
2009-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
A clinical study to evaluate the efficacy and safety of MK0633 in patients with Chronic Obstructive Pulmonary Disease (COPD).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.
Criteria
Inclusion Criteria:- Documented COPD defined by clinical history and spirometry, with symptoms including
dyspnea, wheezing, chest tightness, cough, sputum production, or nocturnal awakening
- Male or postmenopausal females 40 -75 years of age
Exclusion Criteria:
- Impaired renal function
- History of chronic liver disease or persistent liver function test (LFT) abnormalities
- History of recent cardiovascular clinical event
- Evidence of another clinically significant, active pulmonary disorder such as
bronchiectasis or asthma